
Before putting pen to paper it is important to research and plan properly. Successful trials often share similar characteristics. They are:
Therefore, time invested in generating a robust, feasible protocol at the development stage can influence the success of your trial.
| 
 SEPTRE (SPIRIT Electronic Protocol Tool and Resource) is an innovative, web-based software solution that makes it easier to create, manage, and register high-quality protocols for clinical trials.  
The Global Health Network Resources Gateway links to a wealth of useful resources which will assist you with considering data management, safety reporting, ethics and community engagement. 
The Practihc Trial Protocol Tool provides templates and detailed information on what should be included in each section of the Protocol under the 'What should be in a good protocol' option. 
CONSISE has developed standardised research protocols for Influenza, MERS-CoV and Zika Virus (ZIKV) which have all been developed with large numbers of technical experts, including WHO and incorporate knowledge and experience learned from conducting epidemiologic studies all over the world. 
ISARIC is a community of research networks and individuals collaborating to provide a platform through which global, patient‐oriented clinical studies can be developed, executed and shared. Protocols, Informed Consent Forms, Case Report Forms, Standard Operating Procedures, training materials and other research tools are available to support implementation of the research. 
 | 
The SPIRIT 2013 Statement provides evidence-based recommendations for the minimum content of a clinical trial protocol. The recommendations are outlined in a 33-item checklist; the minimum list of items is by no means exhaustive*:
| 
 ADMINISTRATIVE INFORMATION 
1. Title 
2. Trial registration 
3. Protocol version 
4. Funding 
5. Roles and responsibilities 
INTRODUCTION 6. Background and rationale 
7. Objectives 
8. Trial design 
METHODS 
9. Study setting 
10. Eligibility criteria 
11. Interventions 
12. Outcomes 
13. Participant timeline 
14. Sample size 
15. Recruitment 
16. Allocation 
 | 
 17. Blinding (masking) 
18. Data collection 
19. Data management 
20. Statistical methods 
21. Data monitoring 
22. Safety/harms 
23. Auditing 
ETHICS AND DISSEMINATION 24. Research ethics approval 
25. Protocol amendments 
26. Informed consent process 
27. Confidentiality 
28. Declaration of interests 
29. Access to data 
30. Ancillary and post-trial care 
31. Dissemination policy 
 32. Informed consent materials 
33. Biological specimens 
 | 
Community engagement is not specified in this list but is a very important and often overlooked step. Early engagement with the community will help identify relevant local partners and inform decisions about ethical trial design in an LMIC setting.
This engagement can help inform:
| 
 For further information on community engagement consult MESH: This member site is a collaborative open-access web space for people involved in community engagement with health research in LMICs. It provides an online meeting place where community engagement practitioners, researchers, health workers and others can network, share resources and discuss good practice. Click here for a paper called 'Moving targets: The challenges of studying infectious diseases among pregnant women in resource limited settings' which highlights the importance of community engagement and here for a webinar on community engagement in clinical research.  | 
Looking at published protocols, reading articles about trial success factors and lessons learned pieces can help you with developing your protocol. Some examples are below and others can be found on the External Resources tab.
| 
 Example protocols: 
This toolkit from the Children's Hospital of Philadelphia Research Institute has example protocols for both descriptive and observational trials. 
 | 
